Overview
This study aims to evaluate the effect of dexmedetomidine on the level of agitation during the weaning process from mechanical ventilation in critically ill patients.
Eligibility
Inclusion Criteria:
- Adult ICU patients (≥18 years).
- On mechanical ventilation ≥24 hours.
- Clinically ready for weaning.
- Agitation score RASS ≥ +1 during spontaneous breathing trial.
- Intubation for at least 4 days: 2 weeks.
Exclusion Criteria:
- Known hypersensitivity to dexmedetomidine.
- Hemodynamic instability (HR < 50 bpm or MAP < 60 mmHg).
- Neurological impairment affecting level of consciousness.
- Pregnancy or lactation.